Philip MacFaul

Philip MacFaul is a highly experienced Senior Principal Scientist in the DMPK group at Sygnature Discovery, with a career spanning over two decades in pharmaceutical development and research. Previous positions include Senior Principal Scientist at Seda Pharmaceutical Development Services and Principal Scientist at both Redx Pharma and Cyprotex. Philip has also held roles as Team Leader/Principal Scientist at Redx Pharma and Associate Principal Scientist at AstraZeneca, where responsibilities included leading DMPK design and optimization for various drug discovery projects. Early career experience includes a Research Scientist role at Avecia, focusing on dye and formulation optimization, and a Research Associate position at the National Research Council of Canada. Academic credentials include a BSc/DPhil in Chemistry from the University of York.